Skip to main content

Articles

Page 55 of 77

  1. Gene knockout technologies involving programmable nucleases have been used to create knockouts in several applications. Gene editing using Zinc-finger nucleases (ZFNs), Transcription activator like effectors (...

    Authors: Sumitra Shankar, Ahalya Sreekumar, Deepti Prasad, Ani V. Das and M. Radhakrishna Pillai
    Citation: Cancer Cell International 2018 18:169
  2. Drug resistance prevents the effective treatment of cancers. DNA methylation has been found to participate in the development of cancer drug resistance.

    Authors: Dabing Huang, Yong Wang, Yifu He, Gang Wang, Wei Wang, Xinghua Han, Yubei Sun, Lin Lin, Benjie Shan, Guodong Shen, Min Cheng, Geng Bian, Xiang Fang, Shilian Hu and Yueyin Pan
    Citation: Cancer Cell International 2018 18:168
  3. Inflammation is a major player in breast cancer (BC) progression. Allograft-inflammatory factor-1 (AIF1) is a crucial mediator in the inflammatory response. AIF1 reportedly plays a role in BC, but the mechanis...

    Authors: Ferial Amira Slim, Geneviève Ouellette, Kaoutar Ennour-Idrissi, Simon Jacob, Caroline Diorio and Francine Durocher
    Citation: Cancer Cell International 2018 18:167
  4. Mitochondrial fragmentation drastically regulates the viability of pancreatic cancer through a poorly understood mechanism. The present study used erlotinib to activate mitochondrial fragmentation and then inv...

    Authors: Jun Wan, Jie Cui, Lei Wang, Kunpeng Wu, Xiaoping Hong, Yulin Zou, Shuang Zhao and Hong Ke
    Citation: Cancer Cell International 2018 18:165

    The Retraction Note to this article has been published in Cancer Cell International 2019 19:286

  5. Primary or acquired resistance to cetuximab often occurs during targeted therapy in metastatic colorectal cancer (mCRC) patients. In many cancers, the key role of the long noncoding RNA (lncRNA) urothelial car...

    Authors: Ying-nan Yang, Rui Zhang, Jing-wen Du, Heng-heng Yuan, Yan-jing Li, Xiao-li Wei, Xiao-xue Du, Shu-lin Jiang and Yu Han
    Citation: Cancer Cell International 2018 18:164
  6. Follistatin (FST), an activin-binding protein, inhibits activin action by interfering with activin binding to its receptor. The prognostic value of FST has been studied in various cancers. However, these studi...

    Authors: Pengyu Zhang, Yingxin Ruan, Jun Xiao, Fangfang Chen and Xuejun Zhang
    Citation: Cancer Cell International 2018 18:162
  7. Small cell lung cancer (SCLC) is a highly malignant cancer, and over 70% of patients with SCLC present with the metastatic disease. We aimed to explore some novel differentially expressed genes (DEGs) or micro...

    Authors: Zhonghao Wang, Bei Lu, Lixin Sun, Xi Yan and Jinzhi Xu
    Citation: Cancer Cell International 2018 18:161
  8. In an earlier study, we investigated the expression of tight junction protein claudins (CLDNs) in human osteosarcoma (OS) cells, and the CLDN2 was found to be down-regulated in primary tumor cells compared wit...

    Authors: Xiaowei Zhang, Haiming Wang, Qian Li and Tao Li
    Citation: Cancer Cell International 2018 18:160
  9. While the somatic mutation profiles of renal cell carcinoma (RCC) have been revealed by several studies worldwide, the overwhelming majority of those were not derived from Chinese patients. The landscape of so...

    Authors: Jie Wang, Zhijun Xi, Jianzhong Xi, Hanshuo Zhang, Juan Li, Yuchao Xia and Yuanxue Yi
    Citation: Cancer Cell International 2018 18:159
  10. Osteosarcoma (OS) is one of the most prevalent malignant cancers with lower survival and poor overall prognosis mainly in children and adolescents. Identifying the molecular mechanisms and OS stem cells (OSCs)...

    Authors: Babak Otoukesh, Bahram Boddouhi, Mehdi Moghtadaei, Peyman Kaghazian and Maria Kaghazian
    Citation: Cancer Cell International 2018 18:158
  11. Increasing evidence suggests a critical role for long noncoding RNAs (LncRNAs) and pseudogenes in cancer. Renal cell carcinoma (RCC), the most common primary renal neoplasm, is highly aggressive and difficult ...

    Authors: Binghai Chen, Chengyue Wang, Jin Zhang, Yang Zhou, Wei Hu and Tao Guo
    Citation: Cancer Cell International 2018 18:157
  12. As newly identified Wnt enhancer, R-spondin gene family members have been linked to various cancers; however, their role in isocitrate dehydrogenase-wildtype subtype of human glioblastoma (GBM) cells remains u...

    Authors: Si Liu, Kin Pong U, Jieting Zhang, Lai Ling Tsang, Jiawei Huang, Shui Ping Tu and Xiaohua Jiang
    Citation: Cancer Cell International 2018 18:156
  13. Although mounting non-hereditary colorectal cancer (NHCRC) associated single nucleotide polymorphisms (SNPs) have been observed, no field synopsis and meta-analysis has been conducted through systematically as...

    Authors: Jing Wen, Qian Xu and Yuan Yuan
    Citation: Cancer Cell International 2018 18:155
  14. BORIS (CTCFL) is a DNA binding protein which is involved in tumorigenesis. Although, there are different opinions on the level of gene expression and function of BORIS in normal and cancer tissues, the results...

    Authors: Sara Soltanian and Hesam Dehghani
    Citation: Cancer Cell International 2018 18:154
  15. Chronic inflammation is deemed to play a significant effect on initiation and progression of esophageal squamous cell carcinoma (ESCC). In current study, we investigated the prognostic and predictive role of a...

    Authors: Qiu-Fang Gao, Jia-Cong Qiu, Xiao-Hong Huang, Yan-Mei Xu, Shu-Qi Li, Fan Sun, Jing Zhang, Wei-Ming Yang, Qing-Hua Min, Yu-Huan Jiang, Qing-Gen Chen, Lei Zhang, Xiao-Zhong Wang and Hou-Qun Ying
    Citation: Cancer Cell International 2018 18:153
  16. Several epidemiological researches have indicated that microvessel density (MVD), reflecting angiogenesis, was a negatively prognostic factor of cervical cancer. However, the results were inconsistent. Therefo...

    Authors: Xiaoli Hu, Hailing Liu, Miaomiao Ye and Xueqiong Zhu
    Citation: Cancer Cell International 2018 18:152
  17. Extranodal NK/T-cell lymphoma, nasal type (ENKL) is a distinct clinicopathological entity and EBV-associated disease that is highly aggressive. Many patients had failed to respond to conventional chemotherapy ...

    Authors: Xudong Zhang, Xiaorui Fu, Meng Dong, Zhenzhen Yang, Shaoxuan Wu, Mijing Ma, Zhaoming Li, Xinhua Wang, Ling Li, Xin Li, Zhenchang Sun, Yu Chang, Feifei Nan, Jiaqin Yan, Yun Mao, Mingzhi Zhang…
    Citation: Cancer Cell International 2018 18:150
  18. Marsdenia tenacissima is an herb medicine which has been utilized to treat malignant diseases for decades. The M. tenacissima extract (MTE) shows significant anti-proliferation activity against non-small cell lun...

    Authors: Yan-Na Jiao, Li-Na Wu, Dong Xue, Xi-Juan Liu, Zhi-Hua Tian, Shan-Tong Jiang, Shu-Yan Han and Ping-Ping Li
    Citation: Cancer Cell International 2018 18:149
  19. Arterialized vein flap is a kind of unphysiological flap. Unphysiological reconstruction of blood circulation leads to higher load than that supported by physiological flap and is the culprit of flap swelling,...

    Authors: Zheng Li, Zhen-wei Zhang, Shao-xiao Yu, Jia-chuan Zhuang, Yu-hai Ke, Yi Xiong, Hui-xin Lin and Wen-feng Chen
    Citation: Cancer Cell International 2018 18:148
  20. Drug screening for the identification of compounds with anticancer activity is commonly performed using cell lines cultured under normal oxygen pressure and physiological pH. However, solid tumors are characte...

    Authors: Paola Pellegrini, Jason T. Serviss, Thomas Lundbäck, Nicolo Bancaro, Magdalena Mazurkiewicz, Iryna Kolosenko, Di Yu, Martin Haraldsson, Padraig D’Arcy, Stig Linder and Angelo De Milito
    Citation: Cancer Cell International 2018 18:147
  21. The molecular mechanism of Epstein–Barr virus (EBV)-associated gastric cancer (EBVaGC) remains elusive. A collection of molecular regulators including transcription factor and noncoding RNA (ncRNAs) may affect...

    Authors: Jing-jing Jing, Ze-yang Wang, Hao Li, Li-ping Sun and Yuan Yuan
    Citation: Cancer Cell International 2018 18:146
  22. Ovarian cancer is the fifth leading cause of cancer deaths in women worldwide. LncRNACCAT1 was reported to play a critical role in cell metastasis of ovarian cancer. However, little is known about the detailed me...

    Authors: Yang Mu, Na Li and Yu-Lan Cui
    Citation: Cancer Cell International 2018 18:145
  23. Retinoic acid-induced protein I (RIG-I), known as a cytoplastic pattern recognition receptor, can recognize exogenous viral RNAs, and then initiate immune response. Recently, numerous studies also showed that ...

    Authors: Lujun Chen, Jun Feng, Shaoxian Wu, Bin Xu, You Zhou, Changping Wu and Jingting Jiang
    Citation: Cancer Cell International 2018 18:144
  24. Pancreatic cancer, one of the most aggressive malignancies, ranks the fourth cause of cancer-related death worldwide. Aberrantly expressed long non-coding RNAs (lncRNAs) functioned as oncogenes or tumor suppre...

    Authors: Yong An, Xue-min Chen, Yong Yang, Feng Mo, Yong Jiang, Dong-lin Sun and Hui-hua Cai
    Citation: Cancer Cell International 2018 18:143
  25. Breast cancer is the leading cause of oncological mortality among women. Efficient detection of cancer cells in an early stage and potent therapeutic agents targeting metastatic tumors are highly needed to imp...

    Authors: LingLi Hou, Jiancheng Tu, Fangxiong Cheng, Hongwei Yang, Fei Yu, Minghua Wang, Jiubo Liu, Jinbo Fan and Guojun Zhou
    Citation: Cancer Cell International 2018 18:142
  26. Long non-coding RNA (lncRNA) SNHG5 has been found to play an important role in tumors. Nevertheless, the function and mechanism of lncRNA SNHG5 in osteosarcoma (OS) remains unclear. The purpose of this study w...

    Authors: Cheng Ju, Ruihao Zhou, Jun Sun, Feifei Zhang, Xiaofeng Tang, Kaddie Kwok Chen, Junliang Zhao, Xiaoyong Lan, Shifan Lin, Zhiping Zhang and Xiao-Bin Lv
    Citation: Cancer Cell International 2018 18:141
  27. Aberrant methylation of DNA is a key driver of hepatocellular carcinoma (HCC). In this study, we sought to integrate four cohorts profile datasets to identify such abnormally methylated genes and pathways asso...

    Authors: Guorun Fan, Yaqin Tu, Cai Chen, Haiying Sun, Chidan Wan and Xiong Cai
    Citation: Cancer Cell International 2018 18:140
  28. Both multiple myeloma (MM) and systemic lupus erythematosus (SLE) are associated with abnormal production of plasma cells, although their pathological mechanism of each disease is different. The main character...

    Authors: Ruonan Xu, Ying Fang, Chunmei Hou, Bing Zhai, Zhenyu Jiang, Ning Ma, Liang Wang, Gencheng Han and Renxi Wang
    Citation: Cancer Cell International 2018 18:138
  29. Glioblastoma multiforme (GBM) is a highly aggressive brain tumor in which cancer cells with stem cell-like features, called cancer stem cells (CSCs), were identified. Two CSC populations have been previously i...

    Authors: Bianca Maria Scicchitano, Silvia Sorrentino, Gabriella Proietti, Gina Lama, Gabriella Dobrowolny, Angela Catizone, Elena Binda, Luigi Maria Larocca and Gigliola Sica
    Citation: Cancer Cell International 2018 18:136
  30. Lung, breast, and colorectal malignancies are the leading cause of cancer-related deaths in the world causing over 2.8 million cancer-related deaths yearly. Despite efforts to improve prevention methods, early...

    Authors: Evita G. Weagel, Weston Burrup, Roman Kovtun, Edwin J. Velazquez, Abigail M. Felsted, Michelle H. Townsend, Zachary E. Ence, Erica Suh, Stephen R. Piccolo, K. Scott Weber, Richard A. Robison and Kim L. O’Neill
    Citation: Cancer Cell International 2018 18:135

    The Correction to this article has been published in Cancer Cell International 2019 19:29

  31. Following publication of the original article [1], the authors reported a typing mistake in the title. In this Correction the incorrect and correct titles are shown.

    Authors: Lujun Chen, Jun Feng, Bin Xu, You Zhou, Xiao Zheng, Changping Wu and Jingting Jiang
    Citation: Cancer Cell International 2018 18:134

    The original article was published in Cancer Cell International 2018 18:126

  32. High prevalence of hepatocellular carcinoma (HCC) and typically poor prognosis of this disease that lead to late stage diagnosis when potentially curative therapies are least effective; therefore, development ...

    Authors: Faezeh Hosseinzadeh, Javad Verdi, Jafar Ai, Saieh Hajighasemlou, Iman Seyhoun, Frzad Parvizpour, Fatemeh Hosseinzadeh, Abolfazl Iranikhah and Sadegh Shirian
    Citation: Cancer Cell International 2018 18:133
  33. Non-small cell lung cancer (NSCLC), the most prevalent type of human lung cancer, is characterized by many molecular abnormalities. SH2B1, a member of the SH2-domain containing family, have recently been shown...

    Authors: Shaoqiang Wang, Yingying Zheng, Zhiwei He, Wolong Zhou, Yuanda Cheng and Chunfang Zhang
    Citation: Cancer Cell International 2018 18:132
  34. No data is available on the molecular background of the extra-nodal extension (ENE) of lymph node metastasis (LN) in colorectal cancer (CRC).

    Authors: Matteo Fassan, Luca Vianello, Diana Sacchi, Giuseppe N. Fanelli, Giada Munari, Marco Scarpa, Rocco Cappellesso, Fotios Loupakis, Cristiano Lanza, Roberta Salmaso, Claudia Mescoli, Nicola Valeri, Marco Agostini, Edoardo D’Angelo, Sara Lonardi, Salvatore Pucciarelli…
    Citation: Cancer Cell International 2018 18:131

    The Correction to this article has been published in Cancer Cell International 2019 19:244

  35. Colorectal cancer (CRC) is one of the most common cancers diagnosed and among the commonest causes of cancer-related mortality globally. Despite the various available treatment options, millions of people stil...

    Authors: Adewale Oluwaseun Fadaka, Babajide A. Ojo, Olusola Bolaji Adewale, Temitope Esho and Ashley Pretorius
    Citation: Cancer Cell International 2018 18:130
  36. SOX2 overlapping transcript (SOX2OT) is a long non-coding RNA, over-expressed in human tumor tissues and embryonic cells. Evidences support its function in the cell cycle; however there is no clear mechanism e...

    Authors: Marie Saghaeian Jazi, Nader Mansour Samaei, Seyed Javad Mowla, Babak Arefnezhad and Morteza Kouhsar
    Citation: Cancer Cell International 2018 18:129
  37. Multidrug resistance (MDR) is a major obstacle in breast cancer treatment. The predominant mechanism underlying MDR is an increase in the activity of adenosine triphosphate (ATP)-dependent drug efflux transpor...

    Authors: Shao-hsuan Wen, Shey-chiang Su, Bo-huang Liou, Cheng-hao Lin and Kuan-rong Lee
    Citation: Cancer Cell International 2018 18:128
  38. MicroRNAs are small RNAs (~ 22 nt) that modulate the expression of thousands of genes in tumors and play important roles in the formation of multidrug resistance. In this study, we firstly investigated that miR-4...

    Authors: Fan Feng, Xiaolan Zhu, Chunyan Wang, Liang Chen, Weiping Cao, Yueqin Liu, Qi Chen and Wenlin Xu
    Citation: Cancer Cell International 2018 18:127
  39. Recent studies have suggested that B7-H6, a new member of the B7 family of ligands, not only is a crucial regulator of NK cell-mediated immune responses but also has important clinical implications due to its ...

    Authors: Lujun Chen, Jun Feng, Bin Xu, You Zhou, Xiao Zheng, Changping Wu and Jingting Jiang
    Citation: Cancer Cell International 2018 18:126

    The Correction to this article has been published in Cancer Cell International 2018 18:134

  40. Long non-coding RNAs (lncRNA) are classified as a kind of RNA, which are longer than 200 nucleotides in length and cannot be translated into proteins. Multiple studies have demonstrated that lncRNAs are involv...

    Authors: Dan Dong, Zhongyi Mu, Chenghai Zhao and Mingli Sun
    Citation: Cancer Cell International 2018 18:125
  41. Growing evidence suggests that MiRNAs play essential roles in the initiation and progression of colorectal cancer (CRC). The aberrant expression of miR-384 has been reported in some cancers. However, the role ...

    Authors: Yong-Xia Wang, Hui-Fang Zhu, Zhe-Ying Zhang, Feng Ren and Yu-Han Hu
    Citation: Cancer Cell International 2018 18:124
  42. To investigate the efficacy and safety of concurrent chemoradiotherapy with capecitabine or oxaliplatin in locally advanced (T3-4/N + M0) rectal cancer.

    Authors: Wanghua Chen, Wenling Wang, Yuxin Li, Hongmin Dong, Gang Wang and Xiaokai Li
    Citation: Cancer Cell International 2018 18:123
  43. LncRNAs can regulate miRNAs and mRNAs by sequestering and binding them. Indeed, many researchers have reported lncRNA mediated-competing endogenous RNAs (ceRNAs) could regulate the progression of solid tumors....

    Authors: Xuejiao Yin, Sui Huang, Ruiqi Zhu, Fengjuan Fan, Chunyan Sun and Yu Hu
    Citation: Cancer Cell International 2018 18:122
  44. Local or distant metastasis remains the main course of death in head and neck squamous cell carcinoma (HNSCC) patients. MicroRNAs (miRNAs) have been implicated in metastasis of HNSCC, but the mechanisms of the...

    Authors: Yibo Dong, Yang Zheng, Chundi Wang, Xu Ding, Yifei Du, Laikui Liu, Wei Zhang, Wei Zhang, Yi Zhong, Yunong Wu and Xiaomeng Song
    Citation: Cancer Cell International 2018 18:121
  45. Alternatively activated macrophages in tumor microenvironment is defined as M2 tumor-associated macrophages (M2 TAMs) that promote cancer progression. However, communicative mechanisms between M2 TAMs and canc...

    Authors: Li She, Yuexiang Qin, Juncheng Wang, Chao Liu, Gangcai Zhu, Guo Li, Ming Wei, Changhan Chen, Guancheng Liu, Diekuo Zhang, Xiyu Chen, Yunyun Wang, Yuanzheng Qiu, Yongquan Tian, Xin Zhang, Yong Liu…
    Citation: Cancer Cell International 2018 18:120

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 5.3
    5-year Journal Impact Factor: 5.0
    Source Normalized Impact per Paper (SNIP): 0.920
    SCImago Journal Rank (SJR): 1.257

    Speed 2023
    Submission to first editorial decision (median days): 15
    Submission to acceptance (median days): 110

    Usage 2023
    Downloads: 2,067,719
    Altmetric mentions: 1,052

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here